BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Asia
BioWorld Asia
Oct. 13, 2010
View Archived Issues
Synosia Therapeutics Nabs Potential $725M Pact with UCB
LONDON – Synosia Therapeutics sealed a $725 million pact on its two lead drugs for treating Parkinson's disease with UCB Pharma, and announced the closing of a third round funding of $30 million. (BioWorld International)
Read More
Morphosys Pairs Antibody Platform with Sloning's
Read More
Optical Stimulation Shines New Light on Heart Muscle Cells
Read More
Ablynx Expands Merck Deal for Nanobody Technology
Read More
Diagenic Gets $12M for New Biomarker Strategy
Read More
Biotech Foundations: Biotech VC Larry Bock Uses Start-up Spirit in Science Fest
Read More
Other News To Note
Read More